VENLO, The Netherlands, Jan 8, 2008 (PrimeNewswire via COMTEX) -- QIAGEN (Nasdaq:QGEN) (Frankfurt:QIA) today announced that it has been awarded an exclusive contract by the Singapore Ministry of Health to supply sample preparation solutions and molecular tests for the specific detection of Influenza H5N1 viruses -- better known as avian flu.
The contract with the Singapore Ministry of Health is the latest supply agreement of QIAGEN with public and private institutions engaged in H5N1 surveillance. More than 80 institutes worldwide involved in the surveillance of avian flu infection use procedures and reagents developed and offered by QIAGEN.
Full story
